Evidence map›Paper›PMID 25352592›Full record

ArticleThe Journal of biological chemistry2014

A synthetic antibody fragment targeting nicastrin affects assembly and trafficking of γ-secretase.

Xulun Zhang, Robert Hoey, Akiko Koide, Georgia Dolios, Marcin Paduch, Phuong Nguyen, Xianzhong Wu, Yueming Li, Steven L Wagner, Rong Wang and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Notch Signalling in Breast Development and Cancer.Frontiers in cell and developmental biology · 2021
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Xulun ZhangFrom the Departments of Neurobiology and.
Robert HoeyBiochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois 60637.
Akiko KoideBiochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois 60637.
Georgia Doliosthe Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Marcin PaduchBiochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois 60637.
Phuong Nguyenthe Department of Neurosciences, University of California, San Diego School of Medicine, La Jolla, California 92093, and.
Xianzhong WuMolecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, New York 10065.
Yueming LiMolecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, New York 10065.
Steven L Wagnerthe Department of Neurosciences, University of California, San Diego School of Medicine, La Jolla, California 92093, and.
Rong Wangthe Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Shohei KoideBiochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois 60637.
Sangram S SisodiaFrom the Departments of Neurobiology and ssisodia@bsd.uchicago.edu.
University of Chicago · USIcahn School of Medicine at Mount Sinai · USInstitute of Neurobiology · BGMemorial Sloan Kettering Cancer Center · USUniversity of California, San Diego · US

Funding

Synthetic Antigen Binder CoreU54GM087519 · NIGMS · UNIVERSITY OF CHICAGO · PI ZHOU, MING · 2010 to 2017
$31.9M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
THE NINDS MASS SPECTROMETRY PROTEOMICS CENTER FOR NEUROSCIENCES AT MSSMP30NS061777 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WANG, RONG · 2009 to 2014
$3.9M
Regulation and Function of Gamma-SecretaseR01AG026660 · NIA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI LI, YUEMING · 2005 to 2015
$3.5M
Chaperone Assisted CrystallographyR01GM072688 · NIGMS · UNIVERSITY OF CHICAGO · PI KOSSIAKOFF, ANTHONY A · 2005 to 2012
$2.7M
Optimization of Soluble Gamma-secretase Modulators for the Treatment of AlzheimerU01NS074501 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WAGNER, STEVEN LEE · 2011 to 2015
$1.4M
PROTEOMEX LTQ WORKSTATION SHARED INSTRUMENTATION: PROTEOMICSS10RR022415 · NCRR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WANG, RONG · 2006 to 2006
$424k
NCATS NIH HHS UL1 TR000430NCRR NIH HHS S10 RR022415NIA NIH HHS 01AG026660NIA NIH HHS R01 AG026660NIGMS NIH HHS R01 GM072688NIGMS NIH HHS R01-GM072688NIGMS NIH HHS U54 GM087519NIGMS NIH HHS U54-GM087519NINDS NIH HHS P30 NS061777NINDS NIH HHS U01 NS074501
6 · The paper itself

Abstract

The γ-secretase complex, composed of presenilin, nicastrin (NCT), anterior pharynx-defective 1 (APH-1), and presenilin enhancer 2 (PEN-2), is assembled in a highly regulated manner and catalyzes the intramembranous proteolysis of many type I membrane proteins, including Notch and amyloid precursor protein. The Notch family of receptors plays important roles in cell fate specification during development and in adult tissues, and aberrant hyperactive Notch signaling causes some forms of cancer. γ-Secretase-mediated processing of Notch at the cell surface results in the generation of the Notch intracellular domain, which associates with several transcriptional coactivators involved in nuclear signaling events. On the other hand, γ-secretase-mediated processing of amyloid precursor protein leads to the production of amyloid β (Aβ) peptides that play an important role in the pathogenesis of Alzheimer disease. We used a phage display approach to identify synthetic antibodies that specifically target NCT and expressed them in the single-chain variable fragment (scFv) format in mammalian cells. We show that expression of a NCT-specific scFv clone, G9, in HEK293 cells decreased the production of the Notch intracellular domain but not the production of amyloid β peptides that occurs in endosomal and recycling compartments. Biochemical studies revealed that scFvG9 impairs the maturation of NCT by associating with immature forms of NCT and, consequently, prevents its association with the other components of the γ-secretase complex, leading to degradation of these molecules. The reduced cell surface levels of mature γ-secretase complexes, in turn, compromise the intramembranous processing of Notch.

Indexed as

Amyloid Precursor Protein SecretasesAntibody SpecificityHEK293 CellsHumansIntracellular SpaceMembrane GlycoproteinsProtein BindingProtein Structure, TertiaryProtein TransportProteolysisReceptors, NotchSingle-Chain AntibodiesAmyloid Precursor Protein SecretasesMembrane Glycoproteinsnicastrin proteinReceptors, NotchSingle-Chain AntibodiesAlzheimer DiseaseAmyloid Precursor Protein (APP)CancerNotch ReceptorSynthetic Antibodyγ-Secretase

Identifiers

PMID25352592
PMCPMC4263884
OpenAlexW1993356582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.